Sphera Funds Management Ltd. 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Sphera Funds Management Ltd. disclosed 103 US equity positions worth $541.4m in its Q4 2024 13F filing. The largest position was TEVA at 6.4% of the reported book, followed by BBIO and SNY. Against the Q3 2024 filing, it opened 4 new positions, added to 18 and reduced 20 among the top 50 holdings.
What did Sphera Funds Management Ltd. own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 6.4% | $34.6m | 1,569,181 | -26% | reduced |
| 2 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 4.6% | $24.8m | 905,279 | 7% | added |
| 3 | SNY SANOFI | 3.4% | $18.5m | 384,515 | -6% | reduced | |
| 4 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 3.4% | $18.3m | 1,381,241 | 33% | added |
| 5 | AZN ASTRAZENECA PLC | Healthcare | 2.7% | $14.7m | 225,060 | 18% | added |
| 6 | AMZN AMAZON COM INC | Consumer Cyclical | 2.5% | $13.7m | 62,607 | -41% | reduced |
| 7 | NVMI NOVA LTD | Technology | 2.5% | $13.4m | 68,146 | 31% | added |
| 8 | META META PLATFORMS INC | Communication Services | 2.3% | $12.3m | 21,001 | -28% | reduced |
| 9 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 2.2% | $12.0m | 98,921 | -21% | reduced |
| 10 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 2.2% | $12.0m | 474,103 | 13% | added |
| 11 | ELDN ELEDON PHARMACEUTICALS INC | 1.9% | $10.5m | 2,551,619 | 97% | added | |
| 12 | LLY ELI LILLY & CO | Healthcare | 1.9% | $10.2m | 13,190 | 0% | held |
| 13 | JNJ JOHNSON & JOHNSON | Healthcare | 1.9% | $10.1m | 69,831 | 0% | held |
| 14 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.8% | $9.6m | 228,776 | 17% | added |
| 15 | MSFT MICROSOFT CORP | Technology | 1.7% | $9.4m | 22,327 | -33% | reduced |
| 16 | MRVL MARVELL TECHNOLOGY INC | Technology | 1.6% | $8.7m | 78,611 | -10% | reduced |
| 17 | TSEM TOWER SEMICONDUCTOR LTD | Technology | 1.6% | $8.6m | 166,149 | -21% | reduced |
| 18 | NVO NOVO-NORDISK A S | Healthcare | 1.6% | $8.4m | 98,080 | 26% | added |
| 19 | WIX WIX COM LTD | Technology | 1.6% | $8.4m | 39,253 | 15% | added |
| 20 | GOOG ALPHABET INC | Communication Services | 1.5% | $8.3m | 43,500 | – | new |
| 21 | PHVS PHARVARIS N V | 1.4% | $7.4m | 388,183 | -12% | reduced | |
| 22 | NICE NICE LTD | Technology | 1.3% | $7.2m | 42,500 | -46% | reduced |
| 23 | CYTK CYTOKINETICS INC | Healthcare | 1.3% | $7.2m | 153,021 | -32% | reduced |
| 24 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 1.3% | $7.0m | 91,583 | -40% | reduced |
| 25 | CHECK POINT SOFTWARE TECH LT | 1.2% | $6.7m | 35,635 | -11% | reduced | |
| 26 | APLSUSD APELLIS PHARMACEUTICALS INC | 1.2% | $6.6m | 206,251 | -4% | reduced | |
| 27 | IMTX IMMATICS N.V | Healthcare | 1.2% | $6.5m | 921,111 | 28% | added |
| 28 | ANNX ANNEXON INC | Healthcare | 1.2% | $6.4m | 1,243,039 | – | new |
| 29 | ABBV ABBVIE INC | Healthcare | 1.1% | $6.1m | 34,256 | -10% | reduced |
| 30 | MRK MERCK & CO INC | Healthcare | 1.1% | $5.9m | 59,600 | 0% | held |
| 31 | BHVN BIOHAVEN LTD | Healthcare | 1.1% | $5.8m | 156,494 | 17% | added |
| 32 | RZLT REZOLUTE INC | 1.1% | $5.7m | 1,165,895 | -3% | reduced | |
| 33 | FROG JFROG LTD | Technology | 1.0% | $5.6m | 190,381 | 58% | added |
| 34 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.0% | $5.6m | 236,262 | 318% | added |
| 35 | MERUS N V | 1.0% | $5.5m | 130,532 | -12% | reduced | |
| 36 | NTLA INTELLIA THERAPEUTICS INC | Healthcare | 1.0% | $5.4m | 466,080 | 60% | added |
| 37 | ORA ORMAT TECHNOLOGIES INC | Utilities | 1.0% | $5.3m | 79,000 | – | new |
| 38 | KURA KURA ONCOLOGY INC | Healthcare | 1.0% | $5.3m | 610,087 | 0% | held |
| 39 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 1.0% | $5.3m | 288,539 | 14% | added |
| 40 | SEDG SOLAREDGE TECHNOLOGIES INC | Technology | 0.9% | $5.1m | 375,000 | – | new |
| 41 | ORMAT TECHNOLOGIES INC | 0.9% | $5.0m | 5,037,000 | 0% | held | |
| 42 | NVS NOVARTIS AG | Healthcare | 0.9% | $4.9m | 50,000 | 0% | held |
| 43 | HELP CYBIN INC | 0.9% | $4.7m | 538,111 | -42% | reduced | |
| 44 | SKYE SKYE BIOSCIENCE INC | 0.8% | $4.4m | 1,564,628 | 0% | held | |
| 45 | GSK GSK PLC | Healthcare | 0.8% | $4.4m | 130,000 | 30% | added |
| 46 | ETNBGBP 89BIO INC | 0.8% | $4.4m | 556,532 | 4% | added | |
| 47 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 0.8% | $4.3m | 581,829 | 523% | added |
| 48 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 0.8% | $4.2m | 334,987 | -4% | reduced | |
| 49 | VKTX VIKING THERAPEUTICS INC | Healthcare | 0.8% | $4.2m | 103,270 | -22% | reduced |
| 50 | PLRX PLIANT THERAPEUTICS INC | Healthcare | 0.7% | $3.9m | 297,362 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.